EPICEL AU201A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2019-05-13 for EPICEL AU201A manufactured by Vericel Coportation.

Event Text Entries

[144811184] Quantity affected was 72 units. The assembly date was (b)(6) 2018. This case does not meet the criteria for reporting as an mdr. As per new pmsr combination product reporting guidance serious adverse events for combination products must also be reported.
Patient Sequence No: 1, Text Type: N, H10


[144811185] Cardiac issue [cardiac disorder], pneumonia [pneumonia]. Case description: this spontaneous report was received from a physical therapist on 03-apr-2019 along with additional information on (b)(4) 2019 via a company representative, concerning an adult male patient of an unspecified race who expired after being grafted with cultured epidermal autografts (epicel). The patient was grafted with 72 units of epicel with lot number ee02272 for the thermal burn. The relevant medical history and concomitant medication details were not reported. The assembly date was reported as (b)(6) 2018. Biopsy details were not provided. It was reported that the patient had an epicel graft surgery on (b)(6) 2018 and was grafted with 72 units of cultured epidermal autografts with lot numbers ee02272 for the thermal burn. The product part number was au201a and the sale order number was (b)(4). The qc sterility test was performed and results of pre-release sample type (b)(4) was passed and sterility test results of final product sample type (b)(4) were also reported as passed. Environmental results included personal monitoring of manufacturing which had passed with grade a and b parameters and personnel monitoring of qc sterility which had passed with grade a parameters. The quality control assay was reviewed which included (b)(4) graft inspection, (b)(4) dual stain assay, and (b)(4) endotoxin assay, all were reported as passed. On (b)(6) 2019, the patient expired due to unspecified cardiac issue and pneumonia. Further details including a description of clinical presentations, signs, symptoms, diagnostic tests, and baseline data, diagnosis, and autopsy results were not provided. The outcome of the events was fatal. The reporter assessed the causal relationship of the events, cardiac issue, pneumonia as not related to epicel. The company assessed the events of cardiac disorder and pneumonia as not related to epicel. This events did not meet the criteria for a mdr. Due to the events being assessed as serious and unexpected, as per the epicel package insert, this report will be expedited.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1226230-2019-00001
MDR Report Key8603185
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2019-05-13
Date of Report2019-05-10
Date Mfgr Received2019-04-03
Date Added to Maude2019-05-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLIZ GREKAS
Manufacturer Street64 SIDNEY STREET
Manufacturer CityCAMBRIDGE MA 02139
Manufacturer CountryUS
Manufacturer Postal02139
Manufacturer Phone6175885623
Manufacturer G1VERICEL CORPORATION
Manufacturer Street64 SIDNEY STREET
Manufacturer CityCAMBRIDGE MA 02139
Manufacturer CountryUS
Manufacturer Postal Code02139
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEPICEL
Generic NameEPICEL CULTURED EPIDERMAL AUTOGRAFTS
Product CodeOCE
Date Received2019-05-13
Model NumberAU201A
Lot NumberEE02272
Device Expiration Date2018-01-16
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerVERICEL COPORTATION
Manufacturer Address64 SIDNEY STREET CAMBRIDGE MA 02139 US 02139


Patients

Patient NumberTreatmentOutcomeDate
101. Death; 2. Life Threatening 2019-05-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.